UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 497

Sortiert nach

Measurable residual disease testing in acute myeloid leukaemia

Leukemia, 2017-07, Vol.31 (7), p.1482-1490

2017

Volltextzugriff (PDF)

The war on clones: a Darwinian enigma

Blood, 2021-06, Vol.137 (22), p.3008-3009

2021

Volltextzugriff (PDF)

Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center

Leukemia, 2015-02, Vol.29 (2), p.312-320

2015

Volltextzugriff (PDF)

Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia

Leukemia, 2016-01, Vol.30 (1), p.48-56

2016

Volltextzugriff (PDF)

Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia

Leukemia, 2016-03, Vol.30 (3), p.708-715

2016

Volltextzugriff (PDF)

Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study

The Lancet (British edition), 2002-11, Vol.360 (9343), p.1361-1368

2002

Volltextzugriff (PDF)

Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989-2012

Leukemia, 2016-01, Vol.30 (1), p.24-31

2016

Volltextzugriff (PDF)

A simple one-tube assay for immunophenotypical quantification of leukemic stem cells in acute myeloid leukemia

Leukemia, 2016-02, Vol.30 (2), p.439-446

2016

Volltextzugriff (PDF)

Evaluating ivosidenib for the treatment of acute myeloid leukemia

Expert opinion on pharmacotherapy, 2020-12, Vol.21 (18), p.2205-2213

2020

Volltextzugriff (PDF)

Nilotinib in patients with Ph + chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up results

Leukemia, 2012-06, Vol.26 (6), p.1189-1194

2012

Volltextzugriff (PDF)

Improved risk stratification by the integration of the revised International Prognostic Scoring System with the Myelodysplastic Syndromes Comorbidity Index

European journal of cancer (1990), 2014-12, Vol.50 (18), p.3198-3205

2014

Volltextzugriff (PDF)

Aberrant marker expression patterns on the CD34+CD38− stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission

Leukemia, 2007-08, Vol.21 (8), p.1700-1707

2007

Volltextzugriff (PDF)

Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study

Leukemia, 2016-01, Vol.30 (1), p.57-64

2016

Volltextzugriff (PDF)

Improved survival for children and young adolescents with acute myeloid leukemia: a Dutch study on incidence, survival and mortality

Leukemia, 2019-06, Vol.33 (6), p.1349-1359

2019

Volltextzugriff (PDF)

Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the prospective PREDICT trial

Haematologica (Roma), 2013-02, Vol.98 (2), p.172-178

2013

Volltextzugriff (PDF)

ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0

Annals of oncology, 2023-09, Vol.34 (9), p.734-771

2023

Volltextzugriff (PDF)

The myelodysplastic syndromes flow cytometric score: a three-parameter prognostic flow cytometric scoring system

Leukemia, 2016-03, Vol.30 (3), p.658-665

2016

Volltextzugriff (PDF)

Treatment and outcome of 2904 CML patients from the EUTOS population-based registry

Leukemia, 2017-03, Vol.31 (3), p.593-601

2017

Volltextzugriff (PDF)

Intensified chemotherapy inspired by a pediatric regimen combined with allogeneic transplantation in adult patients with acute lymphoblastic leukemia up to the age of 40

Leukemia, 2011-11, Vol.25 (11), p.1697-1703

2011

Volltextzugriff (PDF)

Immunohistochemical profiling based on Bcl-2, CD10 and MUMI expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma

The Journal of pathology, 2006-04, Vol.208 (5), p.714-723

2006

Volltextzugriff (PDF)

MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia

Leukemia, 2004-08, Vol.18 (8), p.1380-1390

2004

Volltextzugriff (PDF)

Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

Leukemia, 2020-10, Vol.34 (10), p.2820-2820

2020

Volltextzugriff (PDF)

1 – 25 von 497

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(463)
Mit Volltextzugriff
(433)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(349)
Life Sciences & Biomedicine
(342)
Humans
(332)
Hematology
(191)
Male
(186)
Middle Aged
(186)
Female
(179)
Biological And Medical Sciences
(174)
Medical Sciences
(169)
Adult
(161)
Oncology
(151)
Aged
(136)
Hematologic And Hematopoietic Diseases
(105)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(103)
Adolescent
(81)
Leukemia
(75)
Prognosis
(72)
Treatment Outcome
(68)
Acute Myeloid Leukemia
(55)
Aged, 80 And Over
(51)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(66)
Leukemia
(66)
Haematologica
(26)
Alzheimer's & Dementia
(23)
Journal Of Clinical Oncology
(17)
Leukemia Research
(16)
Bone Marrow Transplantation
(14)
European Journal Of Haematology
(11)
Nederlands Tijdschrift Voor Geneeskunde
(11)
Netherlands Journal Of Medicine
(10)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Measurable residual disease testing in acute myeloid leukaemia

The war on clones: a Darwinian enigma

Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center

Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia

Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia

Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study

Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989-2012

A simple one-tube assay for immunophenotypical quantification of leukemic stem cells in acute myeloid leukemia

Evaluating ivosidenib for the treatment of acute myeloid leukemia

Nilotinib in patients with Ph + chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up results

Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia

Improved risk stratification by the integration of the revised International Prognostic Scoring System with the Myelodysplastic Syndromes Comorbidity Index

Aberrant marker expression patterns on the CD34+CD38− stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission

Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome

Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study

Improved survival for children and young adolescents with acute myeloid leukemia: a Dutch study on incidence, survival and mortality

Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the prospective PREDICT trial

ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0

The myelodysplastic syndromes flow cytometric score: a three-parameter prognostic flow cytometric scoring system

Treatment and outcome of 2904 CML patients from the EUTOS population-based registry

Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trial

Intensified chemotherapy inspired by a pediatric regimen combined with allogeneic transplantation in adult patients with acute lymphoblastic leukemia up to the age of 40

Immunohistochemical profiling based on Bcl-2, CD10 and MUMI expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma

MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia

Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

Suchergebnisse filtern